Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Why are Cancer Cell Lines Useful?

Acidosis and Tumor Progression

TARDIS: The Improved Method of Detecting Breast Cancer

Microfluidic cancer treatment screen combined with flow cytometry

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Pediatric Cancer

Cancer Diagnosis

What is Merkel Cell Carcinoma?

Myc Mutations and Cancer

Metastatic Migration in Cancer may be Influenced by Metabolism

See more featured articles »

Assay for Monitoring and Treating Malignant Brain Tumors

What Role do Biobanks Play in Cancer Research?

Cancer Symptoms

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Cancer Research

Hypoxia Markers and Their Importance

Is Cancer a Metabolic Disorder?

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Extracellular Vesicles as Floating Cancer Biomarkers

Cancer Glossary

CDK9 and Cancer

Cancer Prognosis

Cancer Epidemiology

Overview of Cell Viability and Cytotoxicity

Cancer Management

Targeted Cancer Therapies

What Causes Cancer?

Insights into Oncofertility

Cancer Prevention: Lowering your Risk

What is the Tumor Microenvironment?

Investigating the Molecular Mechanisms of Cancer

What is Cancer of Unknown Primary?

The Biochemistry of Breast Cancer Screening

Caring for a Loved One with Cancer

Effects of Social and Economic Deprivation on Cancer Mortality

Secondary Brain Cancer

Living with Cancer Pain

The Effects of Cancer on Family Life

Using Biomarkers to Detect Cancer

Cancer Pain

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Cancer Pathophysiology

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Secondary Lung Cancer

Cancer Pain Management

What is Cancer?

Transforming Cancer Care through Genomic Testing

What is Immunochemotherapy?

Cutaneous Manifestations of Internal Malignancy

Hot vs Cold: the differences between tumor types

Exploiting Enzymes in Cancer Diagnosis and Therapy

Cancer Classification

The Cancer Cell Surface Proteome as a Therapeutic Target

British Pioneers in Cancer Biology

Cancer Screening Considerations: Balancing the Benefits and Risks

What is Tumorigenesis?

Cancer History

Insight into Cancer Vaccines

Latest Cancer News and Research

New high-throughput biological sensors track cellular lipid molecules

Inside every cell are lipid molecules that make up cellular membranes, helping organelles communicate and respond to stress.

2 Jul 2026

USC scientists target brain inflammation to prevent Alzheimer's disease

An interdisciplinary team at the USC Center for Personalized Brain Health (CPBH) is targeting a family of enzymes that can increase the risk of inflammation in the brains of people with the APOE4 gene variation-the most significant genetic risk factor for late-onset Alzheimer's-as a way to prevent the disease.

2 Jul 2026

Targeted therapy doubles progression-free survival in rare bile duct cancer

Results of the ongoing eNRGy trial, a single-arm, multicenter, global phase 2 clinical trial evaluating zenocutuzumab in solid tumors positive for Neuregulin 1 (NRG1) gene fusions, reported manageable side effects and clinically meaningful efficacy – including a near doubling of progression-free survival compared to expectations with standard of care – in previously treated patients with advanced NRG1-positive cholangiocarcinoma.

2 Jul 2026

Evolutionary noncoding RNAs reveal new targets for cancer therapy

In cancer research, one person's junk is increasingly becoming another person's treasure. Scientists have now uncovered new evidence showing how recently evolved "junk DNA" genetic elements can become integrated into ancient cellular pathways that regulate cancer.

1 Jul 2026

Study potential new therapeutic strategy for patients with ATRX-mutant gliomas

A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common genetic alterations in glioma rewires the cancer cell genome to fuel tumor progression, suggesting a potential new therapeutic strategy for patients with ATRX-mutant gliomas.

1 Jul 2026

Engineered CAR T cells show promise against myeloproliferative neoplasms

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, in new research led by UCL and University of Oxford researchers.

1 Jul 2026

Imaging scans detect prostate cancer progression despite stable PSA levels

Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of prostate-specific antigen (PSA), a protein in the blood that doctors routinely monitor for cancer progression, according to an analysis led by researchers at Weill Cornell Medicine and Duke University.

1 Jul 2026

Flavonoid-rich foods may blunt breast cancer risk tied to genetics

Higher flavodiet scores were associated with lower breast cancer risk among 93,271 UK Biobank females followed for a median of 11.8 years. The inverse association was particularly evident in women with high genetic risk, but the observational study cannot prove causation.

1 Jul 2026

New portable ultrasound device enhances breast cancer screening accuracy

For people at high risk of developing breast cancer, yearly mammograms may not be enough to detect tumors early.

1 Jul 2026

Reversing macrophage metabolism may improve cancer immunotherapy outcomes

Tumor-associated macrophages (TAMs) are among the most abundant immune cells in the tumor microenvironment.

1 Jul 2026

LEF1 and niche-derived factors regulate T cell stemness across chronic diseases

T cells are an elite fighting force of the immune system, seeking out and destroying diseased cells. But in a prolonged campaign against a chronic condition - like a viral infection, or cancer - the body needs a steady supply of these killer troops.

1 Jul 2026

Fatty liver disease fuels aggressive metastatic colorectal cancer spread

Researchers at VIB and KU Leuven, with international partners, have uncovered how fatty liver disease can fuel the most aggressive form of metastatic colorectal cancer.

1 Jul 2026

German study identifies therapeutic Achilles' heel for advanced colorectal cancer

A team led by researchers from the German Cancer Research Center (DKFZ) and the HI-STEM* Stem Cell Institute has discovered a promising new approach to treating advanced colorectal cancer.

1 Jul 2026

CAR-T cell therapy shows potential to eliminate aggressive glioblastoma

A study led by a researcher based at King's College London and McMaster University in Canada reveals how CAR-T cell therapy, a treatment that engineers a patient's own immune cells to recognize and attack cancer, could be used to treat glioblastoma.

1 Jul 2026

Advanced imaging technology unlocks exosome potential for disease diagnosis

Tiny particles released by most human cells may be promising targets for diagnosis and treatment of an array of diseases from cancer to Alzheimer's, but scientists have struggled to see them and study them in detail.

1 Jul 2026

New bacterial enzyme blueprint could accelerate cancer treatment development

A team of researchers at the University of Warwick and Monash University has solved a puzzle that's stumped drug developers for decades: how bacteria naturally create multiple versions of powerful cancer therapies.

1 Jul 2026

Alexandre Detappe wins ERC grant for nanomedicine-based cancer immunotherapy

The ERC (European Research Council) Proof of Concept grant awarded to Alexandre Detappe (Gustave Roussy/Institut Strauss/Université Paris-Saclay/Inserm) will fund the Nano-BITE project, which aims to improve the ability of the immune system to fight solid tumors through nanomedicine.

1 Jul 2026

Cancer's biggest treatment challenge may be getting solved 250 miles above Earth

For more than two decades, precision oncology has been promoted as the future of cancer treatment, matching therapies to the unique biology of a patient's tumor.

1 Jul 2026

New AI framework outperforms conventional biomarkers in predicting cancer survival

Digestive system cancers, including hepatobiliary and gastrointestinal malignancies, remain a major global oncological burden. Although immune checkpoint inhibitors have changed the treatment landscape for some patients, their overall efficacy remains limited, with only about 15% to 30% of patients achieving durable clinical benefit.

1 Jul 2026

Dual-target CAR-T therapy shows promise against aggressive brain tumors

Researchers at McMaster University have developed a new cancer immunotherapy strategy that can simultaneously attack deadly brain tumors and the immune cells that help them grow.

1 Jul 2026